Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease.
about
Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to UnravelMitochondrial dysfunction in inflammatory bowel diseaseInflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologiesMaternal obesity induces gut inflammation and impairs gut epithelial barrier function in nonobese diabetic mice.Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.Management of Crohn's disease in smokers: is an alternative approach necessary?Tumor necrosis factor-α-induced colitis increases NADPH oxidase 1 expression, oxidative stress, and neutrophil recruitment in the colon: preventive effect of apocynin.mtDNA haplogroup and single nucleotide polymorphisms structure human microbiome communities.Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling.Experimental colitis in mice is attenuated by topical administration of chlorogenic acid.Induction of dsRNA-activated protein kinase links mitochondrial unfolded protein response to the pathogenesis of intestinal inflammation.Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease.NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.Mitochondria: sensors and mediators of innate immune receptor signaling.Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).Absence of the NOD2 protein renders epithelia more susceptible to barrier dysfunction due to mitochondrial dysfunction.Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease.HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function.Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease.Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies.Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.IL-10 counteracts proinflammatory mediator evoked oxidative stress in Caco-2 cells.Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation.Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease--a pilot study.Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients.Association between SOD1, CAT, GSHPX1 polymorphisms and the risk of inflammatory bowel disease in the Polish population.Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis.Implications of Antioxidant Systems in Inflammatory Bowel Disease.Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.
P2860
Q26773008-D95756B1-F853-48EA-8C6F-A24D7724A992Q26781311-AB6DDB7E-F7F3-46A0-8C4D-A11EB364CA73Q28236897-69EFBC60-BDAD-42A0-85B1-70BA32DF3DB8Q33729648-2E87BA23-92BA-4DC7-8C33-9B3F722E2A9DQ33785337-21E51D9A-E4BD-4282-9D3D-99BFEDDF7B38Q34028909-B413461F-7167-463B-AD5F-4566AACF2F80Q34207197-92E20C68-40C7-46EE-9156-FF02F74B8161Q34525212-351EA749-F61C-48C3-94BF-CB6332C25A7FQ34893991-49E094FF-9AC6-46AA-AB41-A44D0CB8326CQ35065914-4E5A0122-CF92-41FC-8DD5-452F429168E5Q35205924-971C6C58-73BB-43F6-BCBA-768C34766D8FQ35626127-39AC488B-BED6-4FC4-B0A6-C56DA953E27AQ35888498-A3D4A160-1B5E-408E-BA95-695627FCF497Q36201694-4C67B952-822F-40D2-81F6-F7438BDA2B03Q36341390-F7D574DA-998B-401D-B25F-DDF9D5FAAD4CQ37258771-9DE40DF8-50C3-433F-A7C1-11DDFC08AFDCQ37993640-2A3926A3-4DEC-48BE-94AD-06175289626DQ38113765-2A449793-14C2-481C-86AE-52DA5E6E97D1Q38550831-DA74C259-C8EB-4DA0-9E1A-EBD2E1344B8BQ38610164-DA1F4012-50DE-4D14-B74F-7F121DDB5077Q38705787-4C694948-85D2-4948-85C0-8F927897A4A6Q38711919-C9805633-1F3B-4E5C-B71F-379AE6F6FFD5Q38861231-D9A95266-562F-43D8-B93D-FCCF064DFF8FQ39351075-6EFE321D-600D-43C0-ACBA-9DD6D51C2B59Q39381101-D34B99E4-15B3-4303-85DD-6B81F76583EBQ39458419-A76EA4C1-2307-48A9-B672-943EDD4752C6Q42151220-1DA0D65E-3493-466D-BF93-C89F253EE040Q42775670-093990AB-C6F9-4947-822F-758B6CC40077Q43948099-2E771497-84FE-4070-80A8-311E0EF074F1Q44172750-D02E7369-EA29-40E1-A652-EE05E344FF7AQ47192939-910FDC82-072C-49D9-AADF-899F8D553F92Q54601212-309963E0-184B-41AC-908B-AEB168D55084Q55023436-E03BE5C2-A7FC-4BB1-8B67-BD2693427229Q55073227-66804F72-6C21-4E6A-902E-F45B2A48C60BQ55154729-2E492486-4DE8-4672-8EAD-A461E3FF1184
P2860
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@en
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@nl
type
label
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@en
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@nl
prefLabel
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@en
Mitochondrial dysfunction, per ...... e and treated Crohn's disease.
@nl
P2093
P2860
P50
P356
P1476
Mitochondrial dysfunction, per ...... ve and treated Crohn's disease
@en
P2093
Guillermo Sáez
Inés Moret
José-Enrique O'Connor
Julio Ponce
Marcial Martínez
Marisa Iborra
P2860
P356
10.1002/IBD.21027
P577
2010-01-01T00:00:00Z